Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 7/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | TOP2A | P11388 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.41 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3467102 | 0.88 | CA1 (0.61) | RAB9ASMN1; SMN2HSD17B10CA1NPC1 | |
| SCHEMBL3466778 | 0.78 | CA1 (0.53) | RAB9ASMN1; SMN2CA1NPC1PTPN1 | |
| SCHEMBL3468755 | 0.75 | CA1 (0.57) | RAB9ASMN1; SMN2CA1NPC1ALDH1A1 | |
| SCHEMBL3467362 | 0.73 | CA1 (0.54) | RAB9ASMN1; SMN2CA1NPC1ALDH1A1 | |
| SCHEMBL3467985 | 0.73 | CA1 (0.57) | RAB9ASMN1; SMN2CA1NPC1ALDH1A1 | |
| SCHEMBL3467631 | 0.72 | ALDH1A1 (0.58) | SMN1; SMN2HSD17B10CA1ALDH1A1CA2 | |
| SCHEMBL28972615 | 0.69 | RAB9A (0.66) | RAB9ASMN1; SMN2NPC1PTPN1ALDH1A1 | |
| SCHEMBL3467783 | 0.68 | ALDH1A1 (0.55) | SMN1; SMN2HSD17B10POLBALDH1A1 | |
| SCHEMBL14970871 | 0.68 | RAB9A (0.74) | RAB9ASMN1; SMN2NPC1PTPN1ALDH1A1 | |
| SCHEMBL3467085 | 0.65 | SMN1; SMN2 (0.51) | RAB9ASMN1; SMN2HSD17B10POLBNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010073011-A2 | COMPOUNDS USEFUL AS MEDICAMENTS | BETAGENON AB (SE) | 2010-07-01 | — | — | WO | claimed |
| WO-2010075542-A1 | CDK INHIBITORS | CURIS, INC. (US) | 2010-07-01 | — | — | WO | disclosed |
| WO-2010073011-A2 | COMPOUNDS USEFUL AS MEDICAMENTS | BETAGENON AB (SE) | 2010-07-01 | — | — | WO | disclosed |